DE69841593D1 - Verfahren und Zusammensetzungen für die Diagnose und die Behandlung von Krankheiten, die mit Eisenüberschuss oder Eisenmangel assoziiert sind - Google Patents
Verfahren und Zusammensetzungen für die Diagnose und die Behandlung von Krankheiten, die mit Eisenüberschuss oder Eisenmangel assoziiert sindInfo
- Publication number
- DE69841593D1 DE69841593D1 DE69841593T DE69841593T DE69841593D1 DE 69841593 D1 DE69841593 D1 DE 69841593D1 DE 69841593 T DE69841593 T DE 69841593T DE 69841593 T DE69841593 T DE 69841593T DE 69841593 D1 DE69841593 D1 DE 69841593D1
- Authority
- DE
- Germany
- Prior art keywords
- iron
- diagnosis
- compositions
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87601097A | 1997-06-13 | 1997-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69841593D1 true DE69841593D1 (de) | 2010-05-12 |
Family
ID=25366786
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69835519T Expired - Lifetime DE69835519T2 (de) | 1997-06-13 | 1998-06-12 | Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. |
DE69841593T Expired - Lifetime DE69841593D1 (de) | 1997-06-13 | 1998-06-12 | Verfahren und Zusammensetzungen für die Diagnose und die Behandlung von Krankheiten, die mit Eisenüberschuss oder Eisenmangel assoziiert sind |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69835519T Expired - Lifetime DE69835519T2 (de) | 1997-06-13 | 1998-06-12 | Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. |
Country Status (8)
Country | Link |
---|---|
US (3) | US6391852B1 (de) |
EP (2) | EP0988316B1 (de) |
JP (1) | JP2002506438A (de) |
AT (2) | ATE462717T1 (de) |
AU (1) | AU745403B2 (de) |
CA (1) | CA2293808C (de) |
DE (2) | DE69835519T2 (de) |
WO (1) | WO1998056814A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7026116B1 (en) * | 1996-04-04 | 2006-04-11 | Bio-Rad Laboratories, Inc. | Polymorphisms in the region of the human hemochromatosis gene |
US6140305A (en) * | 1996-04-04 | 2000-10-31 | Bio-Rad Laboratories, Inc. | Hereditary hemochromatosis gene products |
US6849399B1 (en) * | 1996-05-23 | 2005-02-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for diagnosis and treatment of iron misregulation diseases |
DE69835519T2 (de) | 1997-06-13 | 2007-04-05 | Bio-Rad Laboratories, Inc., Hercules | Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. |
US6284732B1 (en) | 1998-12-18 | 2001-09-04 | Bio-Rad Laboratories, Inc. | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
US7160855B2 (en) | 2002-03-14 | 2007-01-09 | Children's Hospital & Research Center At Oakland | Enhancement of iron chelation therapy |
US8981042B2 (en) | 2010-02-19 | 2015-03-17 | Dover Chemical Corporation | Cycloaliphatic polyphosphite polymer stabilizers |
US8563637B2 (en) | 2010-02-19 | 2013-10-22 | Dover Chemical Corporation | Alkylphenol free-liquid polymeric phosphite polymer stabilizers |
US9982112B2 (en) | 2010-02-19 | 2018-05-29 | Dover Chemical Corporation | Copolymeric polyphosphite polymer stabilizers |
US9745425B2 (en) | 2012-06-22 | 2017-08-29 | Dover Chemical Corporation | Cycloaliphatic polyphosphite |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE208609C (de) | ||||
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4434156A (en) | 1981-10-26 | 1984-02-28 | The Salk Institute For Biological Studies | Monoclonal antibodies specific for the human transferrin receptor glycoprotein |
US4511503A (en) | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
GB8325494D0 (en) | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
US4912118A (en) | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
US4711845A (en) | 1984-08-31 | 1987-12-08 | Cetus Corporation | Portable temperature-sensitive control cassette |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
MX12394A (es) | 1987-07-23 | 1993-12-01 | Ciba Geigy Ag | Procedimiento par la obtencion de carbamatos de polietilenglicol. |
IL84331A0 (en) | 1987-11-02 | 1988-04-29 | Yissum Res Dev Co | Pyridoxyl hydrazone derivatives and pharmaceutical compositions containing the same |
EP0346281B1 (de) | 1988-06-08 | 1992-06-17 | Ciba-Geigy Ag | Carbamoylierte Hydroxamsäurederivate und Verfahren zu ihrer Herstellung |
US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5582979A (en) | 1989-04-21 | 1996-12-10 | Marshfield Clinic | Length polymorphisms in (dC-dA)n.(dG-dT)n sequences and method of using the same |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
IL91047A (en) | 1989-07-19 | 1993-06-10 | Yissum Res Dev Co | Zinc complexes for the treatment of free radical- induced diseases |
US5607437A (en) | 1990-07-12 | 1997-03-04 | University Of Miami | Instruments for use in performing gel injection adjustable keratoplasty |
FR2680687A1 (fr) | 1991-08-29 | 1993-03-05 | Etienne Marie Christine | Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales. |
US5420008A (en) | 1991-12-02 | 1995-05-30 | Oriental Yeast Co., Ltd. | Assay method and assay reagent for serum iron or unsaturated iron binding capacity |
GB9209078D0 (en) | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
EP1143253A1 (de) | 1992-07-10 | 2001-10-10 | University Of British Columbia | Verwendung von p97 und Eisenbindungsproteinen als diagnostische und therapeutische Wirkstoffe |
AU5602594A (en) | 1992-11-16 | 1994-06-08 | University Of Florida Research Foundation, Inc. | 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives |
DE69414279T2 (de) | 1993-02-09 | 1999-04-08 | Bayer Corp., Pittsburgh, Pa. | Sulfonamidaminomethylenderivate als Immunsuppressiva |
US5385918A (en) | 1993-02-09 | 1995-01-31 | Miles Inc. | Aminomethylene-peptides as immunosuppressants |
EP0610745A3 (en) | 1993-02-09 | 1994-09-28 | Miles Inc | Novel aminomethylene derivatives as immunosuppressants. |
EP0689433A4 (de) | 1993-03-16 | 1999-10-20 | Univ Nebraska | Neue metallbindende verbindungen, und verfahren und zusammensetzungen für ihre verwendung zur behandlung von metall-giftigkeit |
JP3585180B2 (ja) | 1993-05-11 | 2004-11-04 | 三菱化学株式会社 | 新規なヒトタンパク質およびそれをコードする遺伝子 |
DE4327226A1 (de) | 1993-08-13 | 1995-02-16 | Hoechst Ag | Chelatoren, ihre Herstellung aus den Antibiotika Salmycin A, B oder C und deren Verwendung |
CN1137267A (zh) | 1993-12-16 | 1996-12-04 | 西巴-盖尔基股份公司 | 用作螯合剂的n,n′-二(2-羟基苄基)-乙二胺n,n′-二乙酸衍生物 |
KR0136993B1 (ko) | 1994-09-13 | 1998-04-24 | 김주용 | 비휘발성 메모리 소자 제조방법 |
US5674681A (en) | 1994-12-06 | 1997-10-07 | Rothenberg; Barry E. | Methods to identify hemochromatosis |
US5753438A (en) | 1995-05-08 | 1998-05-19 | Mercator Genetics, Inc. | Method to diagnose hereditary hemochromatosis |
US5705343A (en) | 1995-05-08 | 1998-01-06 | Mercator Genetics, Inc. | Method to diagnose hereditary hemochromatosis |
US5712098A (en) | 1996-04-04 | 1998-01-27 | Mercator Genetics | Hereditary hemochromatosis diagnostic markers and diagnostic methods |
US6140305A (en) * | 1996-04-04 | 2000-10-31 | Bio-Rad Laboratories, Inc. | Hereditary hemochromatosis gene products |
US5872237A (en) | 1996-04-04 | 1999-02-16 | Mercator Genetics, Inc. | Megabase transcript map: novel sequences and antibodies thereto |
US6025130A (en) | 1996-04-04 | 2000-02-15 | Mercator Genetics, Inc. | Hereditary hemochromatosis gene |
US6849399B1 (en) | 1996-05-23 | 2005-02-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for diagnosis and treatment of iron misregulation diseases |
DE69738157T2 (de) | 1996-10-01 | 2008-05-08 | Bio-Rad Laboratories, Inc., Hercules | Polymorphismus und neue gene in der region des menschlichen hemochromatosisgens |
DE69835519T2 (de) | 1997-06-13 | 2007-04-05 | Bio-Rad Laboratories, Inc., Hercules | Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. |
US6284732B1 (en) | 1998-12-18 | 2001-09-04 | Bio-Rad Laboratories, Inc. | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
-
1998
- 1998-06-12 DE DE69835519T patent/DE69835519T2/de not_active Expired - Lifetime
- 1998-06-12 DE DE69841593T patent/DE69841593D1/de not_active Expired - Lifetime
- 1998-06-12 WO PCT/US1998/012436 patent/WO1998056814A1/en active IP Right Grant
- 1998-06-12 EP EP98930243A patent/EP0988316B1/de not_active Expired - Lifetime
- 1998-06-12 US US09/094,964 patent/US6391852B1/en not_active Expired - Lifetime
- 1998-06-12 CA CA002293808A patent/CA2293808C/en not_active Expired - Fee Related
- 1998-06-12 AU AU79681/98A patent/AU745403B2/en not_active Ceased
- 1998-06-12 JP JP50332999A patent/JP2002506438A/ja active Pending
- 1998-06-12 EP EP06016507A patent/EP1757614B1/de not_active Expired - Lifetime
- 1998-06-12 AT AT06016507T patent/ATE462717T1/de not_active IP Right Cessation
- 1998-06-12 AT AT98930243T patent/ATE335759T1/de not_active IP Right Cessation
-
2002
- 2002-03-04 US US10/092,404 patent/US7119170B2/en not_active Expired - Fee Related
-
2006
- 2006-08-08 US US11/501,582 patent/US7374892B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1757614B1 (de) | 2010-03-31 |
DE69835519T2 (de) | 2007-04-05 |
US20030073627A1 (en) | 2003-04-17 |
US7119170B2 (en) | 2006-10-10 |
US6391852B1 (en) | 2002-05-21 |
DE69835519D1 (de) | 2006-09-21 |
AU7968198A (en) | 1998-12-30 |
ATE335759T1 (de) | 2006-09-15 |
US20060287236A1 (en) | 2006-12-21 |
EP1757614A1 (de) | 2007-02-28 |
US7374892B2 (en) | 2008-05-20 |
EP0988316A1 (de) | 2000-03-29 |
CA2293808C (en) | 2006-10-17 |
EP0988316B1 (de) | 2006-08-09 |
AU745403B2 (en) | 2002-03-21 |
CA2293808A1 (en) | 1998-12-17 |
WO1998056814A1 (en) | 1998-12-17 |
JP2002506438A (ja) | 2002-02-26 |
EP0988316A4 (de) | 2003-07-09 |
ATE462717T1 (de) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69536017D1 (de) | Methoden und zusammensetzungen für die behandlung von glomerulonephritis | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
DE3686362D1 (de) | Verfahren zur behandlung von magen-darmstoerungen. | |
DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
ATE266417T1 (de) | Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien | |
DE69628912D1 (de) | Herstellungb und verwendung eines spezifischen gaba-aalpha5 rezeptorligands zur behandlung der erkrankung von alzheimer | |
DE69633717D1 (de) | Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis | |
ATE210127T1 (de) | 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung | |
ATE182180T1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
DE69530933D1 (de) | Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis | |
ATE342067T1 (de) | Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon | |
ATE335759T1 (de) | Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. | |
HK1044169A1 (en) | Vascular adhesion molecules and modulation of their function | |
DE69929787D1 (de) | Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps | |
DE69729954D1 (de) | Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden | |
DE69329656D1 (de) | Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase-peptidantigenen exprimierenden zellen | |
ATE326534T1 (de) | Methode zur behandlung von muskelkrankheiten | |
DE69619187D1 (de) | Verfahren zur behandlung von motorischen defiziten | |
ES2057572T3 (es) | Agentes de reconocimiento. | |
DE59008012D1 (de) | Mittel zur Behandlung von Leder und Pelzen. | |
ATE526995T1 (de) | Stereoisomers von fettsäureanalogen für diagnostische bildgebung | |
ATE321135T1 (de) | Verfahren zur diagnose und behandlung neurologischer erkrankungen | |
PT870036E (pt) | Α-n-acetilglucosaminidase de mamífero sintética e sequências genéticas codificando a mesma | |
ATE352635T1 (de) | Nukleotidsequenz, die für eine flavinmonooxygenase kodiert, das korrespondierende protein, sowie deren verwendungen in diagnostik und therapie | |
ATE203680T1 (de) | Konjugat zur behandlung von entzündungserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |